Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma news

    Tag: pharma news

    You Searched For "pharma news"
    Abbott discovers new strain of HIV, keeping global health community step ahead of virus

    Abbott discovers new strain of HIV, keeping global health community step ahead of virus

    Medical Dialogues Bureau10 Nov 2019 9:00 AM IST
    New Delhi: Abbott announced recently that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1...
    Shilpa Medicare gets USFDA approval for generic equivalent of cancer drug TARCEVA

    Shilpa Medicare gets USFDA approval for generic equivalent of cancer drug TARCEVA

    Farhat Nasim8 Nov 2019 10:00 AM IST
    Erlotinib Tablets, 25 mg, 100 mg, and 150 mg is a generic equivalent of reference listed drug (RLD) TARCEVA used in the treatment of patients with...
    Penalty levied by SEBI on Jubilant Life Sciences reduced to Rs 5 lakh

    Penalty levied by SEBI on Jubilant Life Sciences reduced to Rs 5 lakh

    Medical Dialogues Bureau8 Nov 2019 9:30 AM IST
    "We have found that the appellant in... Jubilant Life Sciences would be liable for a penalty only on one count i.e. for non-disclosure of the China...
    New USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in trouble

    New USFDA warning letters show Glenmark, Lupin, Cadila Healthcare in trouble

    Medical Dialogues Bureau7 Nov 2019 4:20 PM IST
    Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd. and Lupin Ltd. are the latest local medicine makers to be reprimanded by the US Food and Drug...
    Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China

    Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China

    Medical Dialogues Bureau6 Nov 2019 1:26 PM IST
    Mumbai-Indian drugmaker giant Sun Pharma announced today about entering into an agreement with AstraZeneca to enter the Chinese market with novel...
    Novartis gets U.S. nod for long-delayed copycat version of Amgen billion seller Neulasta drug

    Novartis gets U.S. nod for long-delayed copycat version of Amgen billion seller Neulasta drug

    Medical Dialogues Bureau6 Nov 2019 10:32 AM IST
    ZURICH: Novartis on Tuesday won U.S. approval for its long-delayed version of Amgen's $4 billion seller Neulasta drug, helping the Swiss drugmaker in...
    Biocon gets EIR from USFDA for Bengaluru biologics unit

    Biocon gets EIR from USFDA for Bengaluru biologics unit

    Medical Dialogues Bureau6 Nov 2019 9:19 AM IST
    New Delhi: Biopharmaceutical firm Biocon on Tuesday said it has received an establishment inspection report (EIR) from the US health regulator for its...
    Most Serious: USFDA issues Class 1 recall on Abbotts CentriMag blood pumping system

    Most Serious: USFDA issues Class 1 recall on Abbotts CentriMag blood pumping system

    Medical Dialogues Bureau5 Nov 2019 1:05 PM IST
    The U.S. Food and Drug Administration on Monday classified the recall of Abbott Laboratories' CentriMag blood pumping system following the death of a...
    Zydus Cadila receives warning letter from USFDA for Moraiya-based formulation facility

    Zydus Cadila receives warning letter from USFDA for Moraiya-based formulation facility

    Medical Dialogues Bureau5 Nov 2019 12:57 PM IST
    New Delhi: Drug firm Zydus Cadila on Monday said it has received a warning letter from the US health regulator for its Moraiya-based formulation...
    Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr

    Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr

    Medical Dialogues Bureau5 Nov 2019 12:55 PM IST
    New Delhi: Sun Pharma Advanced Research Company (SPARC) on Monday reported a net loss of Rs 63.16 crore for the quarter ended September 30 of the...
    Strides Pharma Ranitidine tablets within acceptable NDMA limits, says USFDA

    Strides Pharma Ranitidine tablets within acceptable NDMA limits, says USFDA

    Medical Dialogues Bureau4 Nov 2019 4:31 PM IST
    New Delhi: Drug firm, Strides Pharma recently announced that the USFDA issued a statement1 on November 1, 2019, providing an update with the latest...
    GSK Benlysta gets European nod for treatment of children with lupus

    GSK Benlysta gets European nod for treatment of children with lupus

    Medical Dialogues Bureau4 Nov 2019 9:15 AM IST
    New Delhi: GlaxoSmithKline (GSK) plc recently announced that the European Commission has adopted a decision to extend to children five years and...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok